Chengdu Kanghua Biological Products Co., Ltd.
SZSE:300841.SZ
79.25 (CNY) • At close November 27, 2023
Overzicht | Financiële gegevens
Bedrijfsnaam | Chengdu Kanghua Biological Products Co., Ltd. |
Symbool | 300841.SZ |
Munteenheid | CNY |
Prijs | 64.68 |
Beurswaarde | 8,709,162,000 |
Dividendpercentage | 4.05% |
52-weken bereik | 55.52 - 111.97 |
Industrie | Biotechnology |
Sector | Healthcare |
CEO | Mr. Qinghan Wang |
Website | https://www.kangh.com |
An error occurred while fetching data.
Over Chengdu Kanghua Biological Products Co., Ltd.
Chengdu Kanghua Biological Products Co., Ltd. engages in the research, development, production, sale, and technical service of biological products in China. It offers group ACYW135 meningococcal polysaccharide vaccines; and freeze-dried human diploid cell rabies vaccines. The company also develops seasonal influenza vaccines without preservatives, which completed phase III clinical trials;
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (CNY)
Cijfers zijn in miljoenen (CNY)